Consequences of Pathogen Lists: Why Some Diseases May Continue to Plague Us.
| Autor: | Brett-Major DM; Department of Preventive Medicine and Biostatistics, F. Edward Hébert School of Medicine, Uniformed Services University, Bethesda, Maryland., Racine T; Centre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Québec, Université Laval, Québec City, Canada.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., Kobinger GP; Department of Immunology, University of Manitoba, Winnipeg, Canada.; Department of Pathology and Laboratory Medicine, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Centre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Québec, Université Laval, Québec City, Canada.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2019 May; Vol. 100 (5), pp. 1052-1055. |
| DOI: | 10.4269/ajtmh.18-0801 |
| Abstrakt: | The current strategy used by many funding agencies for determining how money is spent on research to help prevent infectious disease outbreaks is based on pathogen-specific priority lists. Listing disease threats provides focus for business and research planning conducive to specific goals of developing a drug, or a vaccine, or other particular product. But, this singular type of focus has consequences. This perspective explores the consequences of lists, and describes how parallel programming independent of disease lists that address what we need to do to prevent and mitigate emerging disease risks may provide benefits out of reach of a singular focus on what products we need to have. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|